Lobe Sciences Ltd. (LOBE.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.7 Million CAD | 81.81% |
| 2022 | -25.87 Million CAD | -13.37% |
| 2021 | -22.82 Million CAD | -563.95% |
| 2020 | -3.43 Million CAD | -537.3% |
| 2019 | 785.98 Thousand CAD | 630.02% |
| 2018 | -148.29 Thousand CAD | -186.31% |
| 2017 | -51.79 Thousand CAD | 7.46% |
| 2016 | -55.97 Thousand CAD | 67.24% |
| 2015 | -170.83 Thousand CAD | -60.53% |
| 2014 | -106.42 Thousand CAD | 20.55% |
| 2013 | -133.95 Thousand CAD | -43.88% |
| 2012 | -93.1 Thousand CAD | -2.31% |
| 2011 | -91 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -568.02 Thousand CAD | 58.71% |
| 2024 Q3 | -426.8 Thousand CAD | 28.33% |
| 2024 Q2 | -595.47 Thousand CAD | -4.83% |
| 2023 FY | -4.7 Million CAD | 81.81% |
| 2023 Q1 | -1.79 Million CAD | 55.58% |
| 2023 Q3 | -312.1 Thousand CAD | 53.12% |
| 2023 Q4 | -1.37 Million CAD | -340.83% |
| 2023 Q2 | -665.75 Thousand CAD | 62.96% |
| 2022 Q3 | -3.13 Million CAD | 39.67% |
| 2022 FY | -25.87 Million CAD | -13.37% |
| 2022 Q4 | -4.04 Million CAD | -29.1% |
| 2022 Q1 | -4.57 Million CAD | 73.16% |
| 2022 Q2 | -5.19 Million CAD | -13.56% |
| 2021 FY | -22.82 Million CAD | -563.95% |
| 2021 Q2 | -2.57 Million CAD | -106.81% |
| 2021 Q3 | 11.2 Million CAD | 535.03% |
| 2021 Q1 | -1.24 Million CAD | 13.26% |
| 2021 Q4 | -17.04 Million CAD | -252.11% |
| 2020 Q3 | -318 Thousand CAD | 68.17% |
| 2020 Q1 | -683.27 Thousand CAD | 27.54% |
| 2020 FY | -3.43 Million CAD | -537.3% |
| 2020 Q4 | -1.43 Million CAD | -351.44% |
| 2020 Q2 | -999.2 Thousand CAD | -46.24% |
| 2019 Q1 | -111.76 Thousand CAD | -625.79% |
| 2019 Q2 | -51.95 Thousand CAD | 53.52% |
| 2019 Q3 | 1.06 Million CAD | 2150.13% |
| 2019 Q4 | -942.95 Thousand CAD | -188.53% |
| 2019 FY | 785.98 Thousand CAD | 630.02% |
| 2018 Q3 | -8472.00 CAD | 33.07% |
| 2018 Q2 | -12.65 Thousand CAD | 35.16% |
| 2018 FY | -148.29 Thousand CAD | -186.31% |
| 2018 Q1 | -19.52 Thousand CAD | -123.12% |
| 2018 Q4 | -15.39 Thousand CAD | -81.76% |
| 2017 Q3 | -14.56 Thousand CAD | -62.49% |
| 2017 Q2 | -8961.00 CAD | 62.26% |
| 2017 Q1 | -23.74 Thousand CAD | -67.35% |
| 2017 Q4 | -8750.00 CAD | 39.91% |
| 2017 FY | -51.79 Thousand CAD | 7.46% |
| 2016 Q2 | -10.58 Thousand CAD | 91.48% |
| 2016 FY | -55.97 Thousand CAD | 67.24% |
| 2016 Q1 | -124.32 Thousand CAD | -772.48% |
| 2016 Q3 | -7448.00 CAD | 29.66% |
| 2016 Q4 | -14.18 Thousand CAD | -90.51% |
| 2015 Q2 | -19.29 Thousand CAD | 20.42% |
| 2015 Q1 | -24.25 Thousand CAD | 18.26% |
| 2015 FY | -170.83 Thousand CAD | -60.53% |
| 2015 Q4 | -14.25 Thousand CAD | -9.92% |
| 2015 Q3 | -12.96 Thousand CAD | 32.82% |
| 2014 Q4 | -29.66 Thousand CAD | -2.94% |
| 2014 Q3 | -28.81 Thousand CAD | -21.66% |
| 2014 Q2 | -23.68 Thousand CAD | 31.05% |
| 2014 Q1 | -34.35 Thousand CAD | -27.8% |
| 2014 FY | -106.42 Thousand CAD | 20.55% |
| 2013 Q2 | -37.44 Thousand CAD | -190.44% |
| 2013 Q4 | -26.88 Thousand CAD | 23.76% |
| 2013 Q1 | -12.89 Thousand CAD | 73.28% |
| 2013 FY | -133.95 Thousand CAD | -43.88% |
| 2013 Q3 | -35.26 Thousand CAD | 5.84% |
| 2012 Q4 | -48.25 Thousand CAD | -98.49% |
| 2012 Q1 | -85.95 Thousand CAD | -1602.71% |
| 2012 Q2 | -7645.00 CAD | 91.11% |
| 2012 Q3 | -24.31 Thousand CAD | -217.99% |
| 2012 FY | -93.1 Thousand CAD | -2.31% |
| 2011 Q4 | -5048.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | -91 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 25.128% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | -18.641% |
| Blueberries Medical Corp. | -1.63 Million CAD | -187.845% |
| The BC Bud Corporation | -1.22 Million CAD | -284.57% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 39.047% |
| CordovaCann Corp. | -6.88 Million CAD | 31.626% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | -13.929% |
| Captor Capital Corp. | -11.38 Million CAD | 58.638% |
| City View Green Holdings Inc. | -2.44 Million CAD | -92.247% |
| 1CM Inc. | -913.85 Thousand CAD | -415.108% |
| Global Hemp Group Inc. | -2.58 Million CAD | -82.418% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 0.324% |
| IM Cannabis Corp. | -9.49 Million CAD | 50.439% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -331.263% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 38.626% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 2207.762% |
| Ovation Science Inc. | -813.14 Thousand CAD | -478.904% |
| Pharmadrug Inc. | -13.2 Million CAD | 64.342% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 22.642% |
| RAMM Pharma Corp. | -7.72 Million CAD | 39.031% |
| RIV Capital Inc. | -106.76 Million CAD | 95.591% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | 16.219% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 96.611% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 75.693% |
| 1933 Industries Inc. | -13.36 Million CAD | 64.776% |
| Red Light Holland Corp. | -7.62 Million CAD | 38.283% |
| Top Strike Resources Corp. | -1.72 Million CAD | -173.678% |
| Xebra Brands Ltd. | -1.95 Million CAD | -140.492% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -32.802% |